Business Description
Cardiol Therapeutics is a Canadian company founded in 2017 and based in Oakville, Ontario, that develops medicines aimed at reducing inflammation and scarring in the heart. Its main drug, CardiolRx, is currently being tested in large-scale clinical trials for two serious heart conditions: acute myocarditis and recurring pericarditis. The company is also working on an injectable treatment called CRD-38, which is in early-stage research as a potential therapy for heart failure.
